Net loss narrowed to $3.62 million, or $0.08 per share, from $4.60 million, or $0.11 per share, in the third quarter of 2025. Worldwide Revenue increased 14.5% to $55.70 million from $48.70 million in ...
SI-BONE Q3 2026 earnings: procedure growth, Onyx launch, new DRG tailwinds and reaffirmed guidance signal a strong Q4.
<?xml encoding="utf-8" ?> SI-BONE SIBN reported third-quarter financial results on Monday. The transcript from the company’s ...
SI-BONE, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 55.7 million compared to USD 48.66 ...
Delivered ~20% U.S. procedure volume growth in the third quarterThird Quarter 2026 Financial Highlights (allcomparisons are to the prior year ...
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address ...
Explore the innovative bone scaffolds created by ScaffoldForge, a generative AI model that revolutionizes design speed.
IntroductionHello. I am Fumi Azuma of the Arukun Walking Gymnastics Class.My class is attended by people with truly serious ...
Researchers have developed ScaffoldForge, a generative artificial intelligence (AI) model that designs 3D printed bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results